Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Innovative Techniques and Future Directions in Stroke Research
Published on: May 5, 2023
Association between miR-30 polymorphism and ischemic stroke in Chinese population
Yan-Ping Luo1, Xi-Xi Gu2,2, Chao Liu1
1Department of Laboratory Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, Guangxi Zhuang Autonomous Region, China.
Single-nucleotide polymorphisms (SNPs) in the miR-30 gene, specifically rs2222722, are linked to an increased risk of ischemic stroke (IS). This finding suggests miR-30 gene variations may play a role in IS development.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Ischemic stroke (IS) is a prevalent cerebrovascular disease with incompletely understood causes.
- The miR-30 gene is a potential factor in IS, but its association with single-nucleotide polymorphisms (SNPs) and IS risk remains unexplored.
Purpose of the Study:
- To investigate the relationship between specific miR-30 gene polymorphisms (rs2222722, rs1192037, rs10095483, and rs16827546) and the risk of developing IS.
Main Methods:
- Genotyping of four miR-30 polymorphisms (rs2222722, rs1192037, rs10095483, rs16827546) using the SNPscan technique.
- Analysis involved 248 IS patients and 230 matched controls.
Main Results:
- A significant association was found between the rs2222722 polymorphism and an increased risk of IS.
- Specific genotype (AA vs. GG) and allele (G vs. A) analyses showed significant associations (P < 0.05).
- miR-30a expression levels were significantly higher in IS patients compared to controls (P < 0.05).
Conclusions:
- The rs2222722 polymorphism in the miR-30 gene is significantly associated with an elevated risk of ischemic stroke.
- These findings highlight the potential role of miR-30 gene variations in the pathogenesis of IS within the Chinese population.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

